Dr. Reddys Laboratories Ltd.
BSE: 500124 | NSE: DRREDDY
Mid Cap | Pharmaceuticals & Drugs
1317.75
14.75
(1.13%)
< Home
< Back
Dr. Reddys Laboratories Ltd. News
>>
Dr. Reddy’s Laboratories reports 31% fall in Q2 consolidated net profit
>>
Dr. Reddy's Labs. - Quaterly Results
>>
Dr. Reddy’s Laboratories gets nod for Zytorvi in advanced esophageal cancer
>>
Dr. Reddy’s Laboratories informs about press release
>>
USFDA completes pre-approval inspection at Dr. Reddy’s Visakhapatnam facility
>>
Dr. Reddy's Laboratories launches NIVORZ in India
>>
Dr Reddys Laboratories informs about newspaper publication
>>
USFDA completes GMP inspection at Dr. Reddy's manufacturing facility in Hyderabad
>>
Dr. Reddy's Laboratories rises on getting USFDA’s approval for rituximab biosimilar
>>
Dr. Reddy's Laboratories gets USFDA’s approval for rituximab biosimilar
<<
<
1
2
3
...145
>
>>